-
IBS-Drug Treatment Pulled, CV Side Effects; Drug Combo Better for Migraine Treatment; Pergolide Off the Market, Heart Disease Risk; Hormone Treatment, Does Timing Matter?; FDA Actions
-
In a group of smokers who were hospitalized with cardiac symptoms, a combination of 12 weeks of behavior modification counseling plus pharmacotherapy resulted in higher tobacco abstinence rates, lower re-hospitalization rates, and markedly reduced mortality rates compared with usual care over two years of follow-up.
-
When compared to The Zone, Ornish, or LEARN diets, the very low carbohydrate diet (Atkins), showed that premenopausal, overweight, and obese women lost more weight and had the most beneficial metabolic effects at 12 months.
-
The FDA has approved a new oral tyrosine kinase inhibitor with potent, reversible, selective dual inhibition of epidermal growth factor receptor (EGFR) and ErbB2 kinases.
-
Recommended periodic preventive services are more likely to be performed through a scheduled screening physical examination or other dedicated preventive visits.
-
Because of the high cardiovascular risk associated with prehypertension, both lifestyle and pharmacological interventions should be vigorously utilized to prevent its progression to full-blown hypertension with its associated higher rates of both morbidity and mortality.
-
Risk factors for atrial fibrillation (AF) most prominently include age, hypertension, diabetes, valvular disease, and heart failure.
-
-
Diabetic gastroparesis, delayed gastric emptying associated with diabetes mellitus, may occur in more than 10% of diabetic patients and can be severely symptomatic and refractory to management.
-
12-lead ECG and lead II rhythm strip obtained from a hospitalized, older adult with the sudden onset of palpitations and a heart rate of 210/minute.
